Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 191

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored

Li, Stephen K.H., Martin, Alberto · 2016 · Trends in Molecular Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molmed.2016.02.003

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 93

  1. Mariotto, 2011, Projections of the cost of cancer care in the United States: 2010-2020, J. Natl. Cancer Inst., 103, 117, 10.1093/jnci/djq495 · DOI · Paper page
  2. Jasperson, 2010, Hereditary and familial colon cancer, Gastroenterology, 138, 2044, 10.1053/j.gastro.2010.01.054 · DOI · Paper page
  3. Hampel, 2008, Feasibility of screening for Lynch syndrome among patients with colorectal cancer, J. Clin. Oncol., 26, 5783, 10.1200/JCO.2008.17.5950 · DOI · Paper page
  4. Poulogiannis, 2010, DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome, Histopathology, 56, 167, 10.1111/j.1365-2559.2009.03392.x · DOI · Paper page
  5. Wimmer, 2010, Constitutional mismatch repair-deficiency syndrome, Haematologica, 95, 699, 10.3324/haematol.2009.021626 · DOI · Paper page
  6. Keller, 1996, Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer, Int. J. Cancer, 68, 571, 10.1002/(SICI)1097-0215(19961127)68:5<571::AID-IJC3>3.0.CO;2-W · doi:10.1002/(sici)1097-0215(19961127)68:5<571::aid-ijc3>3.0.co;2-w
  7. Taketo, 2009, Mouse models of colon cancer, Gastroenterology, 136, 780, 10.1053/j.gastro.2008.12.049 · DOI · Paper page
  8. Cressey, 2015, DNA repair sleuths win chemistry Nobel, Nature, 526, 307, 10.1038/nature.2015.18515 · DOI
  9. Lahue, 1989, DNA mismatch correction in a defined system, Science, 245, 160, 10.1126/science.2665076 · DOI · Paper page
  10. Fishel, 1993, The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer, Cell, 75, 1027, 10.1016/0092-8674(93)90546-3 · DOI · Paper page
  11. Leach, 1993, Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer, Cell, 75, 1215, 10.1016/0092-8674(93)90330-S · DOI · Paper page
  12. Lynch, 2015, Milestones of Lynch syndrome: 1895–2015, Nat. Rev. Cancer, 15, 181, 10.1038/nrc3878 · DOI · Paper page
  13. Thibodeau, 1993, Microsatellite instability in cancer of the proximal colon, Science, 260, 816, 10.1126/science.8484122 · DOI · Paper page
  14. Aaltonen, 1993, Clues to the pathogenesis of familial colorectal cancer, Science, 260, 812, 10.1126/science.8484121 · DOI · Paper page
  15. Ionov, 1993, Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis, Nature, 363, 558, 10.1038/363558a0 · DOI · Paper page
  16. Parsons, 1993, Hypermutability and mismatch repair deficiency in RER+ tumor cells, Cell, 75, 1227, 10.1016/0092-8674(93)90331-J · DOI · Paper page
  17. Lee, 2010, Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias, Gastroenterology, 139, 1519, 10.1053/j.gastro.2010.08.001 · DOI
  18. Haugen, 2008, Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer, Cancer Res., 68, 8465, 10.1158/0008-5472.CAN-08-0002 · DOI
  19. Venderbosch, 2015, EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer, PLoS ONE, 10, e0124538, 10.1371/journal.pone.0124538 · doi:10.1371/journal.pone.0124538
  20. Mensenkamp, 2014, Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors, Gastroenterology, 146, 643, 10.1053/j.gastro.2013.12.002 · DOI · Paper page
  21. Pinheiro, 2015, Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation, Br. J. Cancer, 113, 686, 10.1038/bjc.2015.281 · doi:10.1038/bjc.2015.281
  22. Akiyama, 1997, Frequent somatic mutations of hMSH3 with reference to microsatellite instability in hereditary nonpolyposis colorectal cancers, Biochem. Biophys. Res Commun., 236, 248, 10.1006/bbrc.1997.6942 · DOI
  23. Yamamoto, 2005, Single nucleotide polymorphisms in the EXO1 gene and risk of colorectal cancer in a Japanese population, Carcinogenesis, 26, 411, 10.1093/carcin/bgh335 · DOI
  24. Wu, 2001, Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms, Gastroenterology, 120, 1580, 10.1053/gast.2001.25117 · DOI · Paper page
  25. Kocarnik, 2015, Molecular phenotypes of colorectal cancer and potential clinical applications, Gastroenterol. Rep., 3, 269
  26. Nagasaka, 2010, Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers, Cancer Res., 70, 3098, 10.1158/0008-5472.CAN-09-3290 · DOI
  27. Hitchins, 2007, Inheritance of a cancer-associated MLH1 germline epimutation, N. Engl. J. Med., 356, 697, 10.1056/NEJMoa064522 · DOI · Paper page
  28. Li, 2013, The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSalpha, Cell, 153, 590, 10.1016/j.cell.2013.03.025 · DOI · Paper page
  29. Akiyama, 2000, Beta-catenin and adenomatous polyposis coli (APC) mutations in adenomas from hereditary non-polyposis colorectal cancer patients, Cancer Lett., 157, 185, 10.1016/S0304-3835(00)00486-9 · doi:10.1016/s0304-3835(00)00486-9
  30. Huang, 2004, Somatic mutations of APC gene in carcinomas from hereditary non-polyposis colorectal cancer patients, World J. Gastroenterol., 10, 834, 10.3748/wjg.v10.i6.834 · doi:10.3748/wjg.v10.i6.834
  31. Jass, 2003, APC mutation and tumour budding in colorectal cancer, J. Clin. Pathol., 56, 69, 10.1136/jcp.56.1.69 · DOI · Paper page
  32. Korinek, 1997, Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−/− colon carcinoma, Science, 275, 1784, 10.1126/science.275.5307.1784 · DOI · Paper page
  33. Genschel, 1998, Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha, J. Biol. Chem., 273, 19895, 10.1074/jbc.273.31.19895 · DOI · Paper page
  34. Hombauer, 2011, Visualization of eukaryotic DNA mismatch repair reveals distinct recognition and repair intermediates, Cell, 147, 1040, 10.1016/j.cell.2011.10.025 · DOI · Paper page
  35. Pluciennik, 2010, PCNA function in the activation and strand direction of MutLalpha endonuclease in mismatch repair, Proc. Natl. Acad. Sci. U.S.A., 107, 16066, 10.1073/pnas.1010662107 · DOI · Paper page
  36. Dzantiev, 2004, A defined human system that supports bidirectional mismatch-provoked excision, Mol. Cell, 15, 31, 10.1016/j.molcel.2004.06.016 · DOI · Paper page
  37. Goellner, 2015, Exonuclease 1-dependent and independent mismatch repair, DNA Repair, 32, 24, 10.1016/j.dnarep.2015.04.010 · DOI
  38. Zhang, 2005, Reconstitution of 5′-directed human mismatch repair in a purified system, Cell, 122, 693, 10.1016/j.cell.2005.06.027 · DOI · Paper page
  39. Longley, 1997, DNA polymerase delta is required for human mismatch repair in vitro, J. Biol. Chem., 272, 10917, 10.1074/jbc.272.16.10917 · DOI · Paper page
  40. Rada, 2004, Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation, Mol. Cell, 16, 163, 10.1016/j.molcel.2004.10.011 · DOI · Paper page
  41. Langerak, 2007, A/T mutagenesis in hypermutated immunoglobulin genes strongly depends on PCNAK164 modification, J. Exp. Med., 204, 1989, 10.1084/jem.20070902 · DOI
  42. Pena-Diaz, 2012, Noncanonical mismatch repair as a source of genomic instability in human cells, Mol. Cell, 47, 669, 10.1016/j.molcel.2012.07.006 · DOI
  43. Zhang, 1999, Apoptosis induced by overexpression of hMSH2 or hMLH1, Cancer Res., 59, 3021
  44. Luo, 2004, ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage, Mol. Cell. Biol., 24, 6430, 10.1128/MCB.24.14.6430-6444.2004 · DOI
  45. Chen, 2004, Proteolysis of the mismatch repair protein MLH1 by caspase-3 promotes DNA damage-induced apoptosis, J. Biol. Chem., 279, 27542, 10.1074/jbc.M400971200 · DOI
  46. Mao, 2012, Modulation of microRNA processing by mismatch repair protein MutLalpha, Cell Res., 22, 973, 10.1038/cr.2012.18 · DOI
  47. Kim, 2009, Biogenesis of small RNAs in animals, Nat. Rev. Mol. Cell Biol., 10, 126, 10.1038/nrm2632 · DOI · Paper page
  48. Gregory, 2004, The Microprocessor complex mediates the genesis of microRNAs, Nature, 432, 235, 10.1038/nature03120 · DOI · Paper page
  49. Qian, 2013, Prognostic significance of microRNA-16 expression in human colorectal cancer, World J. Surg., 37, 2944, 10.1007/s00268-013-2205-4 · DOI
  50. Faltejskova, 2012, Identification and functional screening of microRNAs highly deregulated in colorectal cancer, J. Cell. Mol. Med., 16, 2655, 10.1111/j.1582-4934.2012.01579.x · DOI
  51. Zheng, 2014, Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma, Br. J. Cancer, 111, 1985, 10.1038/bjc.2014.489 · DOI
  52. Valeri, 2010, MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2), Proc. Natl. Acad. Sci. U.S.A., 107, 21098, 10.1073/pnas.1015541107 · DOI · Paper page
  53. Svrcek, 2013, Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases, Carcinogenesis, 34, 828, 10.1093/carcin/bgs408 · DOI
  54. Valeri, 2010, Modulation of mismatch repair and genomic stability by miR-155, Proc. Natl. Acad. Sci. U.S.A., 107, 6982, 10.1073/pnas.1002472107 · DOI · Paper page
  55. Louis, 2014, The gut microbiota, bacterial metabolites and colorectal cancer, Nat. Rev. Microbiol., 12, 661, 10.1038/nrmicro3344 · DOI · Paper page
  56. Wang, 2014, Toll-like receptors and cancer: MYD88 mutation and inflammation, Front. Immunol., 5, 367, 10.3389/fimmu.2014.00367 · DOI · Paper page
  57. Song, 2014, Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis, Immunity, 40, 140, 10.1016/j.immuni.2013.11.018 · DOI · Paper page
  58. Wang, 2014, Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis, Immunity, 41, 1052, 10.1016/j.immuni.2014.11.009 · DOI · Paper page
  59. Foran, 2010, Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6, Mol. Cancer Res., 8, 471, 10.1158/1541-7786.MCR-09-0496 · DOI
  60. Patel, 2015, IL6 mediates immune and colorectal cancer cell cross-talk via miR-21 and miR-29b, Mol. Cancer Res., 13, 1502, 10.1158/1541-7786.MCR-15-0147 · DOI
  61. Tseng-Rogenski, 2012, Oxidative stress induces nuclear-to-cytosol shift of hMSH3, a potential mechanism for EMAST in colorectal cancer cells, PLoS ONE, 7, e50616, 10.1371/journal.pone.0050616 · DOI
  62. Tseng-Rogenski, 2015, Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells, Gastroenterology, 148, 579, 10.1053/j.gastro.2014.11.027 · DOI
  63. De Simone, 2015, Th17-type cytokines, IL-6 and TNF-alpha synergistically activate STAT3 and NF-κB to promote colorectal cancer cell growth, Oncogene, 34, 3493, 10.1038/onc.2014.286 · DOI · Paper page
  64. Win, 2015, Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives, Gut, 64, 101, 10.1136/gutjnl-2013-306567 · DOI
  65. Peterson, 2014, Intestinal epithelial cells: regulators of barrier function and immune homeostasis, Nat. Rev. Immunol., 14, 141, 10.1038/nri3608 · DOI · Paper page
  66. Myant, 2013, ROS production and NF-kappaB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation, Cell Stem Cell, 12, 761, 10.1016/j.stem.2013.04.006 · DOI · Paper page
  67. Ding, 2015, Mismatch repair proteins recruit DNA methyltransferase 1 to sites of oxidative DNA damage, J. Mol. Cell Biol.
  68. Castellarin, 2012, Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma, Genome Res., 22, 299, 10.1101/gr.126516.111 · DOI · Paper page
  69. Kostic, 2012, Genomic analysis identifies association of Fusobacterium with colorectal carcinoma, Genome Res., 22, 292, 10.1101/gr.126573.111 · DOI · Paper page
  70. Gao, 2015, Microbiota disbiosis is associated with colorectal cancer, Front. Microbiol., 6, 20, 10.3389/fmicb.2015.00020 · DOI · Paper page
  71. Li, 2012, Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice, Carcinogenesis, 33, 1231, 10.1093/carcin/bgs137 · DOI · Paper page
  72. Sommer, 2015, Site-specific programming of the host epithelial transcriptome by the gut microbiota, Genome Biol., 16, 62, 10.1186/s13059-015-0614-4 · DOI · Paper page
  73. Donohoe, 2012, The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation, Mol. Cell, 48, 612, 10.1016/j.molcel.2012.08.033 · DOI · Paper page
  74. Donohoe, 2014, A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner, Cancer Disc., 4, 1387, 10.1158/2159-8290.CD-14-0501 · DOI · Paper page
  75. Mathers, 2012, Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial, Lancet. Oncol., 13, 1242, 10.1016/S1470-2045(12)70475-8 · DOI
  76. Burn, 2011, Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial, Lancet, 378, 2081, 10.1016/S0140-6736(11)61049-0 · DOI · Paper page
  77. McIlhatton, 2011, Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model, Cancer Prev. Res., 4, 684, 10.1158/1940-6207.CAPR-10-0319 · doi:10.1158/1940-6207.capr-10-0319
  78. Mladenova, 2011, The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon, Gut, 60, 350, 10.1136/gut.2010.208314 · DOI
  79. Ait Ouakrim, 2015, Aspirin, ibuprofen, and the risk of colorectal cancer in Lynch syndrome, J. Natl. Cancer Inst., 107, dvj170, 10.1093/jnci/djv170 · DOI
  80. Ogino, 2011, Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field, Gut, 60, 397, 10.1136/gut.2010.217182 · DOI · Paper page
  81. Ogino, 2011, Cancer immunology – analysis of host and tumor factors for personalized medicine, Nat. Rev. Clin. Oncol., 8, 711, 10.1038/nrclinonc.2011.122 · DOI · Paper page
  82. Ogino, 2013, Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease, Modern Pathol., 26, 465, 10.1038/modpathol.2012.214 · DOI · Paper page
  83. Tafe, 2015, Targeted next-generation sequencing for hereditary cancer syndromes: a focus on Lynch syndrome and associated endometrial cancer, J. Mol. Diagn., 17, 472, 10.1016/j.jmoldx.2015.06.001 · DOI
  84. Pritchard, 2012, ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing, J. Mol. Diagn., 14, 357, 10.1016/j.jmoldx.2012.03.002 · DOI · Paper page
  85. Nagaraju, 2015, MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers, Tumour Biol.
  86. Balaguer, 2011, Colorectal cancers with microsatellite instability display unique miRNA profiles, Clin. Cancer Res., 17, 6239, 10.1158/1078-0432.CCR-11-1424 · DOI
  87. Han, 2015, Fusobacterium nucleatum: a commensal-turned pathogen, Curr. Opin. Microbiol., 23, 141, 10.1016/j.mib.2014.11.013 · DOI · Paper page
  88. Zelenay, 2015, Cyclooxygenase-dependent tumor growth through evasion of immunity, Cell, 162, 1257, 10.1016/j.cell.2015.08.015 · DOI · Paper page
  89. Lal, 2001, Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor, Cancer Res., 61, 6131
  90. Ai, 2015, Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53, Tumour Biol.
  91. Upreti, 2010, Experimental impact of aspirin exposure on rat intestinal bacteria, epithelial cells and cell line, Hum. Exp. Toxicol., 29, 833, 10.1177/0960327110363333 · doi:10.1177/0960327110363333
  92. Wang, 2003, Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents, Gut, 52, 490, 10.1136/gut.52.4.490 · doi:10.1136/gut.52.4.490
  93. Yin, 2014, DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs, Chem. Biol., 21, 481, 10.1016/j.chembiol.2014.02.009 · DOI

Cited by

See all 191

Metadata

Authors
Li, S. K. H., & Martin, A.
Venue
Trends in Molecular Medicine
Publisher
Elsevier BV
Published
2016-04
Volume
22
Issue
4
Pages
274-289
ISSN
1471-4914 (ISSN-L)
OpenAlex
W2295474335
Cited by
191
References
31
FWCI
4.31
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.